Next, we analyzed the expression correlation between Presenilin1 and Sortilin in glioma datasets from RGAVP, and the results showed that the mRNA level of Presenilin1 maintained a significantly positive correlation with Sortilin in glioma and GBM patients (Fig. 3A–C). This evidence concerns the gene SORT1 and central nervous system cancer.